New Zealand markets closed

Adaptive Biotechnologies Corporation (ADPT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.90+0.19 (+2.46%)
At close: 04:00PM EDT
7.98 +0.08 (+1.01%)
After hours: 07:09PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close7.71
Bid0.00 x 4000
Ask0.00 x 1200
Day's range7.54 - 7.92
52-week range6.20 - 43.40
Avg. volume1,397,078
Market cap1.124B
Beta (5Y monthly)1.07
PE ratio (TTM)N/A
EPS (TTM)-1.63
Earnings date02 Aug 2022 - 08 Aug 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est17.25
  • Motley Fool

    10 Amazing Stocks Under $10 (Part II)

    Because of this stock market crash, some wonderful stocks are super cheap in 2022. Here's a mini-portfolio of innovative companies trading under $10 a share right now.

  • Motley Fool

    Adaptive Biotechnologies Corporation (ADPT) Q1 2022 Earnings Call Transcript

    Ladies and gentlemen, thank you for standing by, and welcome to the Adaptive Biotechnologies first quarter 2022 financial results conference call. In addition, Harlan Robins, Adaptive chief scientific officer and co-founder; Nitin Sood, head of our MRG business; and Sharon Benzeno, head of the immune medicine business, will be available for Q&A. With that, I'll turn the call to Chad Robins.

  • Zacks

    Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Lags Revenue Estimates

    Adaptive Biotechnologies (ADPT) delivered earnings and revenue surprises of -2.33% and 0.26%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?